Skip to main content
. 2021 Sep 2;11:722833. doi: 10.3389/fonc.2021.722833

Figure 4.

Figure 4

The forest plot of studies evaluating the prognostic value of CD133 overexpression in determining the PFS of patients with high-grade gliomas (with 10% cut-off).